ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990

In Brief: Control Grant Review committee Out Of Grants Division Provisional Training Announcement Due

October 10, 1975

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

New Colorado Center Gets Core Grant

February 5, 1988

Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says

June 20, 1997

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011